French Pharmaceuticals & Biotech Most Popular Stocks

Sanofi

Market Cap: €95.3b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Sartorius Stedim Biotech

Market Cap: €16.7b

Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.

Eurofins Scientific

Market Cap: €10.8b

Provides various analytical testing and laboratory services worldwide.

Ipsen

Market Cap: €9.2b

Operates as a biopharmaceutical company worldwide.

ABIVAX Société Anonyme

Market Cap: €5.3b

A clinical-stage biotechnology company, focuses on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.

Virbac

Market Cap: €2.6b

Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific.

Vetoquinol

Market Cap: €911.8m

A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region.

MedinCell

Market Cap: €741.3m

A pharmaceutical company, develops long acting injectables in various therapeutic areas in France.

Valneva

Market Cap: €725.4m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Inventiva

Market Cap: €702.5m

A clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally.

Nanobiotix

Market Cap: €634.5m

Operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs.

Boiron

Market Cap: €506.1m

Manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally.

Euroapi

Market Cap: €278.2m

Develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally.

Eurobio Scientific Société anonyme

Market Cap: €253.9m

Engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and cancer.

Cellectis

Market Cap: €215.9m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.

DBV Technologies

Market Cap: €210.6m

A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.

Genfit

Market Cap: €155.9m

A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.

Transgene

Market Cap: €153.6m

A biotechnology company, designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer in France.

Innate Pharma

Market Cap: €148.9m

Operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally.

OSE Immunotherapeutics

Market Cap: €135.1m

A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.

Adocia

Market Cap: €133.1m

A clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases.

ABIONYX Pharma

Market Cap: €126.2m

A biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases.

Sensorion

Market Cap: €95.3m

A biotechnology company, develops drug candidates for the treatment of inner ear disorders in France.

Eurofins-Cerep

Market Cap: €91.8m

Provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally.

Oncodesign Société Anonyme

Market Cap: €99.4m

Oncodesign Société Anonyme, a biopharmaceutical company, conducts research and development work on new therapeutic and diagnostic tools with pharmaceutical firms, biotech companies, public research institutions, and investment groups.

AB Science

Market Cap: €87.2m

A clinical-stage company, engages in the research, design, development, and marketing of drugs to address pathologies affecting the peripheral and central nervous system, inflammatory diseases, and cancers in France.

MaaT Pharma

Market Cap: €61.8m

A late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival.

Novacyt

Market Cap: €31.9m

Develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors.

Nicox

Market Cap: €29.5m

Operates as an ophthalmology company in France and internationally.

genOway Société anonyme

Market Cap: €27.5m

A biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide.

GenSight Biologics

Market Cap: €22.8m

A clinical-stage biotechnology company, discovers, develops, and commercializes novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system.

Advicenne

Market Cap: €22.3m

A specialty pharmaceutical company, develops, commercializes, and markets treatments for rare renal diseases in France and internationally.

Theranexus Société Anonyme

Market Cap: €19.5m

A biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders.

NFL Biosciences

Market Cap: €17.1m

A biotechnology company, engages in the development of botanical drugs in France.

Poxel

Market Cap: €15.9m

A clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases.

Aelis Farma

Market Cap: €15.0m

A clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France.